Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-F9 Polyclonal Antibody

Catalog #:   PHB87801 Specific References (49) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P00740
Overview

Catalog No.

PHB87801

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human F9 (Asp232-Lys455).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

Plasma thromboplastin component,F9,Christmas factor,Coagulation factor IX,PTC

Purification

Purified by antigen affinity column.

Accession

P00740

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • WESTERN BLOT
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with F9 antibody (PHB87801) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 27 kDa
    Observed MW: 27 kDa
References

Identification and Pathogenicity Analysis of Feline Calicivirus in Shanghai and Guangdong, China., PMID:40503218

Probiotic consortium from poultry strains for supporting gut immunity against pathogens., PMID:40239726

Multiplex, multimodal mapping of variant effects in secreted proteins., PMID:39975210

A humanized monoclonal antibody attenuates fentanyl self-administration and reverses and prevents fentanyl-induced ventilatory depression in rhesus monkeys., PMID:39907778

Seroprevalence of SARS-COV-2 Antibodies Associated with the Use of Personal Protective Equipment in Healthcare Workers., PMID:39749151

Intracranial hemorrhage in an infant leads to the diagnosis and treatment of severe hemophilia B: a case report., PMID:39609856

Epstein-Barr nuclear antigen 1 antibody-based indices are increased in patients with multiple sclerosis., PMID:39577298

High prevalence of antibodies against feline calicivirus in Australian feral and stray cat (Felis catus) populations., PMID:39348486

Recent Advances in Gene Therapy for Hemophilia: Projecting the Perspectives., PMID:39062568

Discovery of crucial cytokines associated with deep vein thrombus formation by protein array analysis., PMID:39026176

High-affinity monoclonal antibodies against the porcine epidemic diarrhea virus S1 protein., PMID:38831363

Etranacogene dezaparvovec-drlb gene therapy for patients with hemophilia B (congenital factor IX deficiency)., PMID:37962325

Anti-GPIb/IX autoantibodies are associated with poor response to dexamethasone combined with rituximab therapy in primary immune thrombocytopenia patients., PMID:37722393

Toxin-antitoxin Genes Expression in Multidrug-resistant Mycobacterium tuberculosis Isolates under Drug Exposure., PMID:37226796

Characterization of a novel Plasmodium falciparum merozoite surface antigen and potential vaccine target., PMID:37122725

Antibodies against a single fraction of Micrurus dumerilii venom neutralize the lethal effect of whole venom., PMID:36528173

[Pancreatic β-cell dedifferentiation detected by flow cytometry]., PMID:36456511

Factor IX antibodies and tolerance in hemophilia B in the Nordic countries - The impact of F9 variants and complications., PMID:35842956

Genome-Wide Association Study and Gene-Based Analysis of Participants With Hemophilia A and Inhibitors in the My Life, Our Future Research Repository., PMID:35814780

Clinical conditions and risk factors for inhibitor-development in patients with haemophilia: A decade-long prospective cohort study in Japan, J-HIS2 (Japan Hemophilia Inhibitor Study 2)., PMID:35689832

Recombinant Aspergillus fumigatus antigens Asp f 3 and Asp f 9 in liposomal vaccine protect mice against invasive pulmonary aspergillosis., PMID:35680499

[Effect of Echinococcus granulosus hydatid cyst fluid protein on allergic rhinitis induced by ovalbumin in mice]., PMID:35537837

Blocking human protein C anticoagulant activity improves clotting defects of hemophilia mice expressing human protein C., PMID:35390147

PRINCIPLES OF DIAGNOSIS AND TREATMENT OF ASKIN'S TUMOR IN CHILDREN: CASE REPORT., PMID:35307693

Pharmacological Profiling of Antifentanyl Monoclonal Antibodies in Combination with Naloxone in Pre- and Postexposure Models of Fentanyl Toxicity., PMID:35153198

The Clinical Genetics of Hemophilia B (Factor IX Deficiency)., PMID:34848993

Molecular analysis of severe hemophilia B in Indian families: Identification of mutational hotspot and novel variants., PMID:34590426

Modified-Live Feline Calicivirus Vaccination Elicits Cellular Immunity against a Current Feline Calicivirus Field Strain in an Experimental Feline Challenge Study., PMID:34578316

Anti-Idiotype scFv Localizes an Autoepitope in the Globular Domain of C1q., PMID:34361054

Haemophilia., PMID:34168126

Recent Advances in the Treatment of Hemophilia: A Review., PMID:34163136

Identification of zebrafish ortholog for human coagulation factor IX and its age-dependent expression., PMID:33974340

A Hepatitis B Virus-Derived Peptide Exerts an Anticancer Effect via TNF/iNOS-producing Dendritic Cells in Tumor-Bearing Mouse Model., PMID:33499256

Antibody-based delivery of interleukin-9 to neovascular structures: Therapeutic evaluation in cancer and arthritis., PMID:33475433

Escherichia coli O157:H7 F9 Fimbriae Recognize Plant Xyloglucan and Elicit a Response in Arabidopsis thaliana., PMID:33352760

Natural history study of factor IX deficiency with focus on treatment and complications (B-Natural)., PMID:33278853

Targeting an engineered cytokine with interleukin-2 and interleukin-15 activity to the neovasculature of solid tumors., PMID:33216834

Molecular analysis of 76 Chinese hemophilia B pedigrees and the identification of 10 novel mutations., PMID:32875744

The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and Challenges., PMID:32726826

Immune Response Mechanisms against AAV Vectors in Animal Models., PMID:31970198

Comparative evaluation of bolus and fractionated administration modalities for two antibody-cytokine fusions in immunocompetent tumor-bearing mice., PMID:31790729

Pragmatic language dysfunction in systemic lupus erythematosus patients: Results from a single center Italian study., PMID:31682630

FGF-7 facilitates the process of psoriasis by inducing TNF-α expression in HaCaT cells., PMID:31555794

Temporally separated feline calicivirus isolates do not cluster phylogenetically and are similarly neutralised by high-titre vaccine strain FCV-F9 antisera in vitro., PMID:31411533

Advances and challenges for hemophilia gene therapy., PMID:31332444

Structural basis for neutralization of hepatitis A virus informs a rational design of highly potent inhibitors., PMID:31039149

Lessons learnt from living donor liver transplantation with ABO-incompatibility: A single-centre experience from southern India., PMID:30848450

Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease., PMID:30610738

Targeted delivery of calreticulin to ED-A fibronectin leads to tumor-growth retardation., PMID:30579890

Datasheet

Document Download

Anti-F9 Polyclonal Antibody.pdf

 

$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-F9 Polyclonal Antibody [PHB87801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only